Advertisement

Annals of Surgical Oncology

, Volume 19, Issue 7, pp 2088–2094 | Cite as

Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer

  • E. C. Smyth
  • M. Capanu
  • Y. Y. Janjigian
  • D. K. Kelsen
  • D. Coit
  • V. E. Strong
  • M. A. Shah
Healthcare Policy and Outcomes

Abstract

Background

Tobacco use increases the risk of developing gastric cancer. We examined the hypothesis that gastric cancer developing in patients with a history of tobacco use may be associated with increased risk of cancer-specific death after curative surgical resection.

Methods

From the Memorial Sloan-Kettering Cancer Center Gastric Cancer prospective surgical database, we collected baseline demographic data and tumor characteristics from all patients who had undergone curative resection for gastric cancer between 1995 and 2009 and who had not received pre- or postoperative chemo- or radiotherapy. A smoking history was defined as >100 cigarettes’ lifetime use. The primary end point was gastric cancer disease-specific survival (DSS); secondary end points were 5-year disease-free survival (DFS) and overall survival (OS). Gastric cancer–specific hazard was modeled by Cox regression.

Results

A total of 699 eligible patients were identified with a median age of 70 years (range 25–96 years); 410 (59%) were current or previous smokers. Smoking was associated with gastroesophageal junction/cardia tumors and white non-Hispanic ethnicity. Multivariate analysis included the following variables: tumor stage, age, performance status, diabetes mellitus, gender, and tumor location. In this analysis, the hazard ratio for gastric cancer DSS in smokers was 1.43 (95% confidence interval 1.08–1.91, P = 0.01). Smoking was also an independent significant risk factor for worse 5-year DFS (hazard ratio 1.46, P = 0.007) and OS (hazard ratio 1.48, P = 0.003). Among 516 patients for whom tobacco pack-year usage was available, both heavy (≥ 20 pack-years) and light (<20 pack-years) tobacco use was significantly associated with DSS, DFS, and OS.

Conclusions

Smoking history appears to be an independent risk factor for death from gastric cancer in patients who have undergone curative surgical resection.

Keywords

Gastric Cancer Overall Survival Smoking History Gastric Cancer Recurrence Cardia Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

Supported in part by the DeGregorio Foundation for Gastroesophageal Cancers.

Financial disclosures

There are no financial disclosures from any author.

References

  1. 1.
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRefGoogle Scholar
  2. 2.
    Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997;72:565–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689–701.PubMedCrossRefGoogle Scholar
  4. 4.
    Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59:39–48.PubMedCrossRefGoogle Scholar
  5. 5.
    Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647–50.PubMedCrossRefGoogle Scholar
  7. 7.
    Ramamoorthy S, Luo L, Luo E, Carethers JM. Tobacco smoking and risk of recurrence for squamous cell cancer of the anus. Cancer Detect Prev. 2008;32:116–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int. 2002;90:228–39.PubMedCrossRefGoogle Scholar
  9. 9.
    Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus–positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010;16:1226–35.PubMedCrossRefGoogle Scholar
  10. 10.
    Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3981–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Coker AL, DeSimone CP, Eggleston KS, Hopenhayn C, Nee J, Tucker T. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005. Gynecol Oncol. 2009;112:365–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Janjigian YY, McDonnell K, Kris MG, et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer. 2010;116:670–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res. 2009;15:5646–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.Google Scholar
  15. 15.
    World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva, Switzerland: World Health Organization; 1998.Google Scholar
  16. 16.
    Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol. 2000;38:637–46.PubMedCrossRefGoogle Scholar
  17. 17.
    Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest. 2006;116:2208–17.PubMedCrossRefGoogle Scholar
  18. 18.
    Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Gazdar AF. Environmental tobacco smoke, carcinogenesis, angiogenesis: a double whammy? Cancer Cell. 2003;4:159–60.PubMedCrossRefGoogle Scholar
  20. 20.
    Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124:36–45.PubMedCrossRefGoogle Scholar
  21. 21.
    Shin VY, Jin HC, Ng EK, Sung JJ, Chu KM, Cho CH. Activation of 5-lipoxygenase is required for nicotine mediated epithelial–mesenchymal transition and tumor cell growth. Cancer Lett. 2010;292:237–45.PubMedCrossRefGoogle Scholar
  22. 22.
    Simán JH, Forsgren A, Berglund G, Florén CH. Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori–infected individuals. Scand J Gastroenterol. 2001;36:208–13.PubMedCrossRefGoogle Scholar
  23. 23.
    Matsuo K, Hamajima N, Ikehara Y, et al. Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiol Infect. 2003;130:227–33.PubMedCrossRefGoogle Scholar
  24. 24.
    Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol. 1996;91:258–63.PubMedGoogle Scholar
  25. 25.
    Qiu HB, Zhang LY, Keshari RP, et al. Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374.PubMedCrossRefGoogle Scholar
  26. 26.
    Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis. 1989;139:194–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Lu LM, Zavitz CC, Chen B, Kianpour S, Wan Y, Stämpfli MR. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol. 2007;178:936–43.PubMedGoogle Scholar
  28. 28.
    Wu AH. Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer. Environ Health Perspect. 1999;107(Suppl 6):873–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Warner KE. Possible increases in the underreporting of cigarette consumption. J Am Stat Assoc. 1978;73(362):314–8.Google Scholar
  30. 30.
    Wald NJ, Nanchahal K, Thompson SG, Cuckle HS. Does breathing other people’s tobacco smoke cause lung cancer? Br Med J (Clin Res Ed). 1986;293(6556):1217–22.CrossRefGoogle Scholar
  31. 31.
    Commission on Life Science. Environmental tobacco smoke: measuring exposures and assessing health effects. Washington, DC: National Academy Press; 1986. http://www.nap.edu/catalog.php?record_id=943.
  32. 32.
    Sung NY, Choi KS, Park EC, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation study. Br J Cancer. 2007;97:700–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102:1012–22.PubMedCrossRefGoogle Scholar
  34. 34.
    Fariña-Sarasqueta A, van Lijnschoten G, Moerland E, et al. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann Oncol. 2010;21:2396–402.PubMedCrossRefGoogle Scholar
  35. 35.
    Ahn JB, Chung WB, Maeda O, et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 2011;117:1847–54.PubMedCrossRefGoogle Scholar
  36. 36.
    Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40.Google Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • E. C. Smyth
    • 1
  • M. Capanu
    • 2
  • Y. Y. Janjigian
    • 1
  • D. K. Kelsen
    • 1
  • D. Coit
    • 3
  • V. E. Strong
    • 3
  • M. A. Shah
    • 1
    • 4
  1. 1.Department of MedicineMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Epidemiology and BiostatisticsMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  4. 4.Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations